{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:26Z","timestamp":1777529306220,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Changzhou science and technology","award":["CE20175021"],"award-info":[{"award-number":["CE20175021"]}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["2017NJMUZD044"],"award-info":[{"award-number":["2017NJMUZD044"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.cca.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T09:27:10Z","timestamp":1544088430000},"page":"130-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Associations of serum markers screening for Down's syndrome with pregnancy outcomes: A Chinese retrospective cohort study"],"prefix":"10.1016","volume":"489","author":[{"given":"Xiaosong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7744-4521","authenticated-orcid":false,"given":"Wei","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-7314","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.12.001_bb0005","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2018.12.001_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1258\/jms.2012.011145","article-title":"First trimester, second trimester, and integrated screening for Down's syndrome in China","volume":"19","author":"Miao","year":"2012","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.cca.2018.12.001_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejogrb.2014.07.018","article-title":"Predictive value of combined serum biomarkers for adverse pregnancy outcomes","volume":"181","author":"Cohen","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cca.2018.12.001_bb0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12884-015-0608-y","article-title":"Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis","volume":"15","author":"Zhong","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.cca.2018.12.001_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-014-3606-9","article-title":"Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein concentrations","volume":"292","author":"Puntachai","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.cca.2018.12.001_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1701-2163(15)30331-5","article-title":"Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes","volume":"37","author":"Tancr\u00e8de","year":"2015","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.cca.2018.12.001_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000458409","article-title":"Predictive value of second-trimester biomarkers and maternal features for adverse pregnancy outcomes","volume":"42","author":"Yefet","year":"2017","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.cca.2018.12.001_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.04.017","article-title":"Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis","volume":"145","author":"Yuan","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cca.2018.12.001_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","article-title":"Quad screen as a predictor of adverse pregnancy outcome","volume":"106","author":"Dugoff","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2013.02.012","article-title":"Association of early-preterm birth with abnormal concentrations of routinely collected first and second-trimester biomarkers","volume":"208","author":"Jelliffe-Pawlowski","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/14767058.2013.815719","article-title":"Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol","volume":"27","author":"Olsen","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.cca.2018.12.001_bb0060","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2018.12.001_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"Williamson","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/586578","article-title":"Preeclampsia 2012","volume":"2012","author":"Eiland","year":"2012","journal-title":"J. Pregnancy"},{"key":"10.1016\/j.cca.2018.12.001_bb0075","article-title":"Maternal serum cadmium concentration during pregnancy and its association with small for gestational age infants: a population-based birth cohort study","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2018.12.001_bb0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","article-title":"Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome","volume":"181","author":"Yaron","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0085","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3109\/14767058.2015.1075503","article-title":"Association between isolated abnormal concentrations of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes","volume":"29","author":"Settiyanan","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.cca.2018.12.001_bb0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.2505","article-title":"Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome","volume":"30","author":"Huang","year":"2010","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.cca.2018.12.001_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0029-7844(95)00390-8","article-title":"Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein","volume":"87","author":"Benn","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/1097-0223(200008)20:8<652::AID-PD882>3.0.CO;2-6","article-title":"Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.cca.2018.12.001_bb0105","first-page":"277","article-title":"Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome","volume":"97","author":"Krause","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/S0002-9378(03)00769-5","article-title":"Unexplained elevated maternal serum alpha-fetoprotein and\/or human chorionic gonadotropin and the risk of adverse outcomes","volume":"189","author":"Chandra","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.12.001_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0301-2115(03)00081-2","article-title":"Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy","volume":"110","author":"Duric","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cca.2018.12.001_bb0120","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/1471-0528.13495","article-title":"Maternal characteristics and midpregnancy serum biomarkers as risk factors for subtypes of preterm birth","volume":"122","author":"Jelliffe-Pawlowski","year":"2015","journal-title":"BJOG"},{"issue":"2014","key":"10.1016\/j.cca.2018.12.001_bb0125","first-page":"807196","article-title":"First trimester biomarkers in the prediction of later pregnancy complications","author":"Kane","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2018.12.001_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811830620X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811830620X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T02:18:17Z","timestamp":1720837097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811830620X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"alternative-id":["S000989811830620X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.12.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of serum markers screening for Down's syndrome with pregnancy outcomes: A Chinese retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}